Search

everythinglearnresearchcommunity

for

Search:↓

Improving hair health and managing conditions can enhance scalp cooling effectiveness in preventing hair loss during chemotherapy.

Alopecia Areata causes emotional stress and stigma, but those with severe hair loss may adapt better.

Comprehensive information and trained nurses are crucial for a better scalp cooling experience during chemotherapy.

A new AI model diagnoses hair and scalp disorders with 92% accuracy, better than previous models.

Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.

Scalp tissue micrografts can effectively treat hair loss by increasing hair density and thickness.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

The scalp microbiome is more diverse and may be more important in hair loss than the gut microbiome.

Phytotherapy offers a safer alternative for managing hair loss with fewer side effects.

No treatment fully prevents hair loss from chemotherapy yet.

Minoxidil and finasteride effectively treat hair loss.

Trichodynia found in 29% of TE or AGA patients, linked to psychological conditions.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Two rare bald spots on the back of the scalp were found to be lupus, not alopecia areata.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Various hair camouflage options help people with hair loss improve appearance.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

The conclusion is that "trichoknesis" should be recognized as a separate condition from trichodynia, characterized by itching instead of pain.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Children's hair loss can be caused by many factors, including autoimmune diseases, emotional stress, genetics, and infections, with treatment and prognosis varying.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

Lichen simplex chronicus on the scalp can be diagnosed by specific hair and skin signs and treated with corticosteroids and therapy.

Alopecia areata affects quality of life more in adolescents than adults.

Scalp diseases change with age and can be hard to tell apart from hair disorders.

Addressing biological changes in lipids, metabolism, and microbiota may help treat hair loss in young Chinese females with oily scalps.

Disease-specific tools better assess alopecia areata's impact on quality of life.